REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farbiopharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Farbiopharma S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Farbiopharma S.A. is based in Ecuador. The head office is in Quito. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on July 27, 2001. The total number of employees is currently 393 (2024). From the latest financial highlights, Farbiopharma S.A. reported a net sales revenue increase of 14.86% in 2024. Its total assets grew by 18.3% over the same period. The enterprise’s net profit margin decreased by 0.96% in 2024.

Headquarters
Guayas E3-296
Quito; Pichincha;

Contact Details: Purchase the Farbiopharma S.A. report to view the information.

Website: http://www.farbiopharma.com

Basic Information
Total Employees:
Purchase the Farbiopharma S.A. report to view the information.
Registered Capital:
Purchase the Farbiopharma S.A. report to view the information.
Financial Auditors:
Purchase the Farbiopharma S.A. report to view the information.
Incorporation Date:
July 27, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Farbiopharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
14.86%▲
Total operating revenue
14.52%▲
Operating profit (EBIT)
16.31%▲
EBITDA
17.19%▲
Net Profit (Loss) for the Period
-2.07%▼
Total assets
18.3%▲
Total equity
9.19%▲
Operating Profit Margin (ROS)
0.19%▲
Net Profit Margin
-0.96%▼
Return on Equity (ROE)
-1.26%▼
Debt to Equity Ratio
7.41%▲
Quick Ratio
-0.36%▼
Cash Ratio
-0.03%▼

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Laboratorios Dr a Bjarner C.A.
 
Laboratorio Farmaceutico Lamosan C.L.
Operfel S.A.
 
Carvagu S.A.
Distribuidora Comercial la Raiz Discomraiz S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo